NeuroMetrix, Inc. (NasdaqCM:NURO) will look for acquisitions. NeuroMetrix has filed for shelf registrations for an amount of $25,000,000. NeuroMetrix intends to use any net proceeds from the sale of the securities offered under the prospectus for general corporate purposes unless otherwise indicated in the applicable prospectus supplement. General corporate purposes may include the acquisition of companies or businesses, repayment and refinancing of debt, working capital and capital expenditures.